These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28126579)

  • 21. Temporal relationship between onset of positive and negative symptoms in the course of attenuated psychotic illness.
    Dishy G; Kennedy L; Lundgren B; Xu Q; Masucci MD; Califano A; Hesson H; Cohen-Romano C; Pia T; Brucato G
    Psychiatry Res; 2020 Nov; 293():113439. PubMed ID: 32942088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of a clinical high risk status among individuals with a family history of psychosis.
    Stowkowy J; Addington J
    Schizophr Res; 2013 Jul; 147(2-3):281-6. PubMed ID: 23611242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of a family history of psychosis for youth at clinical high risk of psychosis.
    Georgopoulos G; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2019 Apr; 13(2):251-256. PubMed ID: 28792113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk for Psychosis Services.
    Foss-Feig JH; Velthorst E; Smith L; Reichenberg A; Addington J; Cadenhead KS; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone WS; Keshavan M; Tsuang MT; Walker EF; Woods SW; Cannon TD; Bearden CE
    J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):582-588. PubMed ID: 30797038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome.
    Carrión RE; Demmin D; Auther AM; McLaughlin D; Olsen R; Lencz T; Correll CU; Cornblatt BA
    J Psychiatr Res; 2016 Oct; 81():95-101. PubMed ID: 27424062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis.
    Lunsford-Avery JR; Orr JM; Gupta T; Pelletier-Baldelli A; Dean DJ; Smith Watts AK; Bernard J; Millman ZB; Mittal VA
    Schizophr Res; 2013 Dec; 151(1-3):148-53. PubMed ID: 24094679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Childhood trauma and clinical high risk for psychosis.
    Loewy RL; Corey S; Amirfathi F; Dabit S; Fulford D; Pearson R; Hua JPY; Schlosser D; Stuart BK; Mathalon DH; Vinogradov S
    Schizophr Res; 2019 Mar; 205():10-14. PubMed ID: 29779964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anomalous self-experiences are strongly associated with negative symptoms in a clinical high-risk for psychosis sample.
    Værnes TG; Røssberg JI; Møller P
    Compr Psychiatry; 2019 Aug; 93():65-72. PubMed ID: 31351243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.
    Schlosser DA; Jacobson S; Chen Q; Sugar CA; Niendam TA; Li G; Bearden CE; Cannon TD
    Schizophr Bull; 2012 Nov; 38(6):1225-33. PubMed ID: 21825282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort.
    Braun A; Liu L; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1379-1388. PubMed ID: 35113189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treating Sleep Problems in Young People at Ultra-High Risk of Psychosis: A Feasibility Case Series.
    Bradley J; Freeman D; Chadwick E; Harvey AG; Mullins B; Johns L; Sheaves B; Lennox B; Broome M; Waite F
    Behav Cogn Psychother; 2018 May; 46(3):276-291. PubMed ID: 29081329
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis.
    Carrión RE; McLaughlin D; Auther AM; Olsen R; Correll CU; Cornblatt BA
    Psychol Med; 2015 Nov; 45(15):3341-54. PubMed ID: 26169626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis.
    Webb JR; Addington J; Perkins DO; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen RK; Seidman LJ; Tarbox SI; Tsuang MT; Walker EF; McGlashan TH; Woods SW
    Schizophr Bull; 2015 Sep; 41(5):1066-75. PubMed ID: 26272875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Greater preference for eveningness is associated with negative symptoms in an ultra-high risk for psychosis sample.
    Shetty JJ; Nicholas C; Nelson B; McGorry PD; Lavoie S; Markulev C; Schäfer MR; Thompson A; Yuen HP; Yung AR; Nieman DH; de Haan L; Amminger GP; Hartmann JA
    Early Interv Psychiatry; 2021 Dec; 15(6):1793-1798. PubMed ID: 33538110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
    Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
    Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anxiety in youth at clinical high risk for psychosis.
    McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.